Since a Swiss physician first recorded the phenomenon in 1609, only a hundred men across all of human history have been documented as born with two penises — a condition so rare it touches perhaps one in five million lives, and so singular that a recent birth in Iraq, involving three, stands alone in all of medical record. Diphallia reminds us that the body's formation is a process of extraordinary precision, and that when that process is disrupted, the consequences reach far beyond anatomy into identity, belonging, and the long work of living with difference. Medicine has learned to intervene
Diphallia: The Rare Condition of Men Born With Two Penises
Cobertura Relacionada
San Sebastián de los Reyes celebra sus fiestas con actuaciones de orquestas españolas de renombre, incluyendo la Orquest…
Google News · Aug 27 Policía busca a hombre que encontró 30 dólares en tienda y se los quedóUn hombre halló 30 dólares mientras hacía compras y decidió quedárselos, lo que generó una búsqueda policial para identi…
El País · Aug 27 Más de 1.300 desaparecidos en Nepal y Tíbet tras colapso glaciar que deja 165 muertosUna violenta riada causada por el colapso de un glaciar en el Himalaya ha dejado al menos 165 muertos y más de 1.300 des…
El Mostrador · Aug 27 Científicos chilenos descubren seis linajes de planarias, posibles nuevas especies con capacidades regenerativasCientíficos chilenos identificaron seis linajes de planarias potencialmente nuevas en distintas latitudes del país, incl…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
This article discusses diphallia, a rare medical condition, with no geopolitical implications.
Lente Económico
Article discusses diphallia, an extremely rare congenital condition affecting ~1 in 5-6 million births with only 100 documented cases. No direct economic implications identified.
Minimal. Affects extremely small patient population (~100 cases globally). Patients may face increased healthcare costs for specialized surgical interventions and urological care, but aggregate market impact is negligible.
No significant policy implications. Medical treatment protocols already established through standard urological surgical practices. Potential minor impact on rare disease research funding allocation.